Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus

Abstract Background Idiopathic normal pressure hydrocephalus (iNPH) is a potentially reversible neurological condition of unresolved etiology characterized by a clinical triad of symptoms; gait disturbances, urinary incontinence, and cognitive deterioration. In the present study, we aimed to elucida...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sara Diana Lolansen, Nina Rostgaard, Søren Norge Andreassen, Anja Hviid Simonsen, Marianne Juhler, Steen Gregers Hasselbalch, Nanna MacAulay
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/4c88aee5e43b41f2bbcd913762540d94
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4c88aee5e43b41f2bbcd913762540d94
record_format dspace
spelling oai:doaj.org-article:4c88aee5e43b41f2bbcd913762540d942021-12-05T12:04:34ZElevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus10.1186/s12987-021-00289-62045-8118https://doaj.org/article/4c88aee5e43b41f2bbcd913762540d942021-12-01T00:00:00Zhttps://doi.org/10.1186/s12987-021-00289-6https://doaj.org/toc/2045-8118Abstract Background Idiopathic normal pressure hydrocephalus (iNPH) is a potentially reversible neurological condition of unresolved etiology characterized by a clinical triad of symptoms; gait disturbances, urinary incontinence, and cognitive deterioration. In the present study, we aimed to elucidate the molecular coupling between inflammatory markers and development of iNPH and determine whether inflammation-induced hyperactivity of the choroidal Na+/K+/2Cl− cotransporter (NKCC1) that is involved in cerebrospinal fluid (CSF) secretion could contribute to the iNPH pathogenesis. Methods Lumbar CSF samples from 20 iNPH patients (10 with clinical improvement upon CSF shunting, 10 without clinical improvement) and 20 elderly control subjects were analyzed with the novel proximity extension assay technique for presence of 92 different inflammatory markers. RNA-sequencing was employed to delineate choroidal abundance of the receptors for the inflammatory markers found elevated in the CSF from iNPH patients. The ability of the elevated inflammatory markers to modulate choroidal NKCC1 activity was determined by addition of combinations of rat version of these in ex vivo experiments on rat choroid plexus. Results 11 inflammatory markers were significantly elevated in the CSF from iNPH patients compared to elderly control subjects: CCL28, CCL23, CCL3, OPG, CXCL1, IL-18, IL-8, OSM, 4E-BP1, CXCL6, and Flt3L. One inflammatory marker, CDCP1, was significantly decreased in iNPH patients compared to control subjects. None of the inflammatory markers differed significantly when comparing iNPH patients with and without clinical improvement upon CSF shunting. All receptors for the elevated inflammatory markers were expressed in the rat and human choroid plexus, except CCR4 and CXCR1, which were absent from the rat choroid plexus. None of the elevated inflammatory markers found in the CSF from iNPH patients modulated the choroidal NKCC1 activity in ex vivo experiments on rat choroid plexus. Conclusion The CSF from iNPH patients contains elevated levels of a subset of inflammatory markers. Although the corresponding inflammatory receptors are, in general, expressed in the choroid plexus of rats and humans, their activation did not modulate the NKCC1-mediated fraction of choroidal CSF secretion ex vivo. The molecular mechanisms underlying ventriculomegaly in iNPH, and the possible connection to inflammation, therefore remains to be elucidated.Sara Diana LolansenNina RostgaardSøren Norge AndreassenAnja Hviid SimonsenMarianne JuhlerSteen Gregers HasselbalchNanna MacAulayBMCarticleNormal pressure hydrocephalusCerebrospinal fluidInflammatory markerBiomarkersChoroid plexusNeurology. Diseases of the nervous systemRC346-429ENFluids and Barriers of the CNS, Vol 18, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Normal pressure hydrocephalus
Cerebrospinal fluid
Inflammatory marker
Biomarkers
Choroid plexus
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Normal pressure hydrocephalus
Cerebrospinal fluid
Inflammatory marker
Biomarkers
Choroid plexus
Neurology. Diseases of the nervous system
RC346-429
Sara Diana Lolansen
Nina Rostgaard
Søren Norge Andreassen
Anja Hviid Simonsen
Marianne Juhler
Steen Gregers Hasselbalch
Nanna MacAulay
Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus
description Abstract Background Idiopathic normal pressure hydrocephalus (iNPH) is a potentially reversible neurological condition of unresolved etiology characterized by a clinical triad of symptoms; gait disturbances, urinary incontinence, and cognitive deterioration. In the present study, we aimed to elucidate the molecular coupling between inflammatory markers and development of iNPH and determine whether inflammation-induced hyperactivity of the choroidal Na+/K+/2Cl− cotransporter (NKCC1) that is involved in cerebrospinal fluid (CSF) secretion could contribute to the iNPH pathogenesis. Methods Lumbar CSF samples from 20 iNPH patients (10 with clinical improvement upon CSF shunting, 10 without clinical improvement) and 20 elderly control subjects were analyzed with the novel proximity extension assay technique for presence of 92 different inflammatory markers. RNA-sequencing was employed to delineate choroidal abundance of the receptors for the inflammatory markers found elevated in the CSF from iNPH patients. The ability of the elevated inflammatory markers to modulate choroidal NKCC1 activity was determined by addition of combinations of rat version of these in ex vivo experiments on rat choroid plexus. Results 11 inflammatory markers were significantly elevated in the CSF from iNPH patients compared to elderly control subjects: CCL28, CCL23, CCL3, OPG, CXCL1, IL-18, IL-8, OSM, 4E-BP1, CXCL6, and Flt3L. One inflammatory marker, CDCP1, was significantly decreased in iNPH patients compared to control subjects. None of the inflammatory markers differed significantly when comparing iNPH patients with and without clinical improvement upon CSF shunting. All receptors for the elevated inflammatory markers were expressed in the rat and human choroid plexus, except CCR4 and CXCR1, which were absent from the rat choroid plexus. None of the elevated inflammatory markers found in the CSF from iNPH patients modulated the choroidal NKCC1 activity in ex vivo experiments on rat choroid plexus. Conclusion The CSF from iNPH patients contains elevated levels of a subset of inflammatory markers. Although the corresponding inflammatory receptors are, in general, expressed in the choroid plexus of rats and humans, their activation did not modulate the NKCC1-mediated fraction of choroidal CSF secretion ex vivo. The molecular mechanisms underlying ventriculomegaly in iNPH, and the possible connection to inflammation, therefore remains to be elucidated.
format article
author Sara Diana Lolansen
Nina Rostgaard
Søren Norge Andreassen
Anja Hviid Simonsen
Marianne Juhler
Steen Gregers Hasselbalch
Nanna MacAulay
author_facet Sara Diana Lolansen
Nina Rostgaard
Søren Norge Andreassen
Anja Hviid Simonsen
Marianne Juhler
Steen Gregers Hasselbalch
Nanna MacAulay
author_sort Sara Diana Lolansen
title Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus
title_short Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus
title_full Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus
title_fullStr Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus
title_full_unstemmed Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus
title_sort elevated csf inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote nkcc1 hyperactivity in rat choroid plexus
publisher BMC
publishDate 2021
url https://doaj.org/article/4c88aee5e43b41f2bbcd913762540d94
work_keys_str_mv AT saradianalolansen elevatedcsfinflammatorymarkersinpatientswithidiopathicnormalpressurehydrocephalusdonotpromotenkcc1hyperactivityinratchoroidplexus
AT ninarostgaard elevatedcsfinflammatorymarkersinpatientswithidiopathicnormalpressurehydrocephalusdonotpromotenkcc1hyperactivityinratchoroidplexus
AT sørennorgeandreassen elevatedcsfinflammatorymarkersinpatientswithidiopathicnormalpressurehydrocephalusdonotpromotenkcc1hyperactivityinratchoroidplexus
AT anjahviidsimonsen elevatedcsfinflammatorymarkersinpatientswithidiopathicnormalpressurehydrocephalusdonotpromotenkcc1hyperactivityinratchoroidplexus
AT mariannejuhler elevatedcsfinflammatorymarkersinpatientswithidiopathicnormalpressurehydrocephalusdonotpromotenkcc1hyperactivityinratchoroidplexus
AT steengregershasselbalch elevatedcsfinflammatorymarkersinpatientswithidiopathicnormalpressurehydrocephalusdonotpromotenkcc1hyperactivityinratchoroidplexus
AT nannamacaulay elevatedcsfinflammatorymarkersinpatientswithidiopathicnormalpressurehydrocephalusdonotpromotenkcc1hyperactivityinratchoroidplexus
_version_ 1718372251409055744